Literature DB >> 9183437

Putative neurosurgical transmission of Creutzfeldt-Jakob disease with analysis of donor and recipient: agent strains.

K H el Hachimi1, M P Chaunu, L Cervenakova, P Brown, J F Foncin.   

Abstract

A woman, aged 59 years, underwent a cortical biopsy that led to the diagnosis of Creutzfeldt-Jakob disease (CJD). A man, aged 46 years, underwent cranial surgery in the same department 3 days later for brain contusion, with an uneventful recovery. Twenty six months later, he developed clinical signs of CJD with a typical EEG pattern. Both cases exhibited features of the 'ataxic' form of the disease with depletion of cerebellar granule cells, without kuru plaques or PrP deposits. PrP deposits were immuno-histochemically observed in the cerebrum, spinal cord and peripheral nerve. Molecular genetic analysis performed on brain tissue revealed the codon 129 polymorphism to be Met129Met in the donor and Met129Val in the recipient. The shared 'cerebellar' phenotype and the genotypic discrepancy between the two patients lead us to postulate that the 'cerebellar' agent strain plays a major role in CJD phenotype and transmission.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183437     DOI: 10.1016/s0764-4469(97)82774-6

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  9 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?

Authors:  Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Paul Brown; Daniela Saverioni; Yuichi Matsuura; Atsuko Takeuchi; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

Review 3.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

Review 4.  Risk of transmission of sporadic Creutzfeldt-Jakob disease by surgical procedures: systematic reviews and quality of evidence.

Authors:  Fernando J García López; María Ruiz-Tovar; Javier Almazán-Isla; Enrique Alcalde-Cabero; Miguel Calero; Jesús de Pedro-Cuesta
Journal:  Euro Surveill       Date:  2017-10

5.  Creutzfeldt-Jakob Disease with a Five-Year Clinical Course, Multicentric Cerebellar Prion Plaques and Prior History of Biopsy-Proven Primary Angiitis of the Central Nervous System: A Case for Iatrogenic Exposure?

Authors:  Kristina Jeon; Jeffrey T Joseph; Gerard H Jansen; Anne Peterson; J David Knox; Valerie L Sim
Journal:  Viruses       Date:  2020-12-08       Impact factor: 5.048

Review 6.  Epidemiological characteristics of human prion diseases.

Authors:  Cao Chen; Xiao-Ping Dong
Journal:  Infect Dis Poverty       Date:  2016-06-02       Impact factor: 4.520

7.  Application of the updated CDC isolation guidelines for health care facilities.

Authors:  Shauna Ely Tarrac
Journal:  AORN J       Date:  2008-03       Impact factor: 0.676

8.  A Novel, Reliable and Highly Versatile Method to Evaluate Different Prion Decontamination Procedures.

Authors:  Hasier Eraña; Miguel Ángel Pérez-Castro; Sandra García-Martínez; Jorge M Charco; Rafael López-Moreno; Carlos M Díaz-Dominguez; Tomás Barrio; Ezequiel González-Miranda; Joaquín Castilla
Journal:  Front Bioeng Biotechnol       Date:  2020-10-29

9.  Vaporized Hydrogen Peroxide and Ozone Gas Synergistically Reduce Prion Infectivity on Stainless Steel Wire.

Authors:  Hideyuki Hara; Junji Chida; Agriani Dini Pasiana; Keiji Uchiyama; Yutaka Kikuchi; Tomoko Naito; Yuichi Takahashi; Junji Yamamura; Hisashi Kuromatsu; Suehiro Sakaguchi
Journal:  Int J Mol Sci       Date:  2021-03-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.